<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_589'>Dysplasia</z:mpath> is the most important marker of progression to <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Intensive endoscopic surveillance with biopsy may identify <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> in a patient with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) </plain></SENT>
<SENT sid="2" pm="."><plain>Close relationship with an experienced gastrointestinal pathologist and thoracic surgeon will improve treatment decisions and patient outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>No intervention is required in patients with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (LGD); continued surveillance is recommended </plain></SENT>
<SENT sid="4" pm="."><plain>Surgical resection is the currently accepted therapy for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Endoscopic ablative therapy remains experimental </plain></SENT>
</text></document>